SG11202106223RA - Methods for detecting neutralizing antibodies to parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp) analog - Google Patents
Methods for detecting neutralizing antibodies to parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp) analogInfo
- Publication number
- SG11202106223RA SG11202106223RA SG11202106223RA SG11202106223RA SG11202106223RA SG 11202106223R A SG11202106223R A SG 11202106223RA SG 11202106223R A SG11202106223R A SG 11202106223RA SG 11202106223R A SG11202106223R A SG 11202106223RA SG 11202106223R A SG11202106223R A SG 11202106223RA
- Authority
- SG
- Singapore
- Prior art keywords
- parathyroid hormone
- pthrp
- pth
- analog
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5032—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on intercellular interactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/635—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962791267P | 2019-01-11 | 2019-01-11 | |
| PCT/IB2020/050200 WO2020144653A1 (en) | 2019-01-11 | 2020-01-10 | Methods for detecting neutralizing antibodies to parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp) analog |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202106223RA true SG11202106223RA (en) | 2021-07-29 |
Family
ID=69326581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202106223RA SG11202106223RA (en) | 2019-01-11 | 2020-01-10 | Methods for detecting neutralizing antibodies to parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp) analog |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US11255842B2 (en) |
| EP (1) | EP3908605A1 (en) |
| JP (1) | JP2022516228A (en) |
| KR (1) | KR20210120009A (en) |
| CN (1) | CN113286818B (en) |
| AU (1) | AU2020207653A1 (en) |
| BR (1) | BR112021011566A2 (en) |
| CA (1) | CA3122231A1 (en) |
| CO (1) | CO2021007715A2 (en) |
| IL (1) | IL284533B2 (en) |
| MX (1) | MX2021007056A (en) |
| SG (1) | SG11202106223RA (en) |
| WO (1) | WO2020144653A1 (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992017602A1 (en) * | 1991-04-05 | 1992-10-15 | The General Hospital Corporation Office Of Technology Affairs | Parathyroid hormone receptor and dna encoding same |
| US20030082179A1 (en) * | 2001-07-03 | 2003-05-01 | Hutchison James Scott | Parathyroid hormone antibodies and related methods |
| WO2014011416A2 (en) * | 2012-07-11 | 2014-01-16 | Biomimetic Therapeutics, Llc | Cell-based assay for neutralizing antibodies |
| JP6755256B2 (en) * | 2015-03-03 | 2020-09-16 | ラジウス ヘルス，インコーポレイテッド | Use of PTHrP analogs to reduce fracture risk |
| GB201706781D0 (en) * | 2017-04-28 | 2017-06-14 | Univ Sheffield | Parathyroid hormone fusion polypeptide |
-
2020
- 2020-01-10 IL IL284533A patent/IL284533B2/en unknown
- 2020-01-10 SG SG11202106223RA patent/SG11202106223RA/en unknown
- 2020-01-10 CA CA3122231A patent/CA3122231A1/en active Pending
- 2020-01-10 AU AU2020207653A patent/AU2020207653A1/en active Pending
- 2020-01-10 KR KR1020217025206A patent/KR20210120009A/en unknown
- 2020-01-10 MX MX2021007056A patent/MX2021007056A/en unknown
- 2020-01-10 WO PCT/IB2020/050200 patent/WO2020144653A1/en active Application Filing
- 2020-01-10 BR BR112021011566-8A patent/BR112021011566A2/en unknown
- 2020-01-10 JP JP2021532150A patent/JP2022516228A/en active Pending
- 2020-01-10 CN CN202080008703.2A patent/CN113286818B/en active Active
- 2020-01-10 EP EP20702369.8A patent/EP3908605A1/en active Pending
-
2021
- 2021-06-11 CO CONC2021/0007715A patent/CO2021007715A2/en unknown
- 2021-07-07 US US17/369,163 patent/US11255842B2/en active Active
-
2022
- 2022-01-07 US US17/571,312 patent/US11680942B2/en active Active
-
2023
- 2023-05-05 US US18/143,636 patent/US20230273187A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US11255842B2 (en) | 2022-02-22 |
| MX2021007056A (en) | 2021-09-10 |
| AU2020207653A1 (en) | 2021-07-01 |
| EP3908605A1 (en) | 2021-11-17 |
| CA3122231A1 (en) | 2020-07-16 |
| US20230273187A1 (en) | 2023-08-31 |
| US20220205978A1 (en) | 2022-06-30 |
| US11680942B2 (en) | 2023-06-20 |
| US20210389300A1 (en) | 2021-12-16 |
| CN113286818A (en) | 2021-08-20 |
| WO2020144653A1 (en) | 2020-07-16 |
| IL284533B2 (en) | 2024-02-01 |
| CO2021007715A2 (en) | 2021-09-30 |
| JP2022516228A (en) | 2022-02-25 |
| BR112021011566A2 (en) | 2021-08-31 |
| KR20210120009A (en) | 2021-10-06 |
| CN113286818B (en) | 2023-07-21 |
| IL284533A (en) | 2021-08-31 |
| IL284533B1 (en) | 2023-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202110889WA (en) | Dosage forms and regimens for amino acid compounds | |
| ZA201806772B (en) | Dual leo satellite system and method for global coverage | |
| WO2010111617A3 (en) | Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use | |
| PT3270957T (en) | A novel complex comprising a cell penetrating peptide, a cargo and a tlr peptide agonist for treatment of glioblastoma | |
| KR20220036364A (en) | Computerized systems and methods for assisted picking processes | |
| MY184194A (en) | Wire setting apparatus of tabbing apparatus and wire setting method using same | |
| ZA201606745B (en) | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same | |
| WO2012145665A3 (en) | Method of drug delivery for pth, pthrp and related peptides | |
| SG11201707318PA (en) | Method for detecting monoclonal antibody using mass spectrometry | |
| IL284491A (en) | System and method for multi-modal dosing device | |
| EP3118212A4 (en) | Cell penetrating peptide and method for delivering biologically active substance using same | |
| MX2017013333A (en) | Method for protein purification. | |
| GB201914106D0 (en) | System and method for software architecture redesign | |
| EP3790887A4 (en) | Chemical platform assisted proximity capture (cap-c) | |
| EP3334827A4 (en) | Aptamer biosensors useful for detecting hormones, hormone mimics, and metabolites thereof | |
| IL284533A (en) | Methods for detecting neutralizing antibodies to parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp) analog | |
| WO2014209893A3 (en) | Alpha-/beta-polypeptide analogs of parathyroid hormone (pth) and method of using same | |
| GB2580639B (en) | System and method for inspecting a moving structure | |
| MX2020010886A (en) | Methods for purification of polypeptides using polysorbates. | |
| WO2012119004A3 (en) | Parathyroid hormone analogs, compositions and uses thereof | |
| MX2018004322A (en) | Method for detecting neutralizing antibodies against recombinant man insulin in man serum. | |
| PH12017501798A1 (en) | An assembly and method for handling components | |
| PT3980137T (en) | Method and liquid-mixing system for providing a liquid mixture | |
| SG10201903424RA (en) | ANTI HUMAN Gas6 MONOCLONAL ANTIBODY | |
| SG11202000639RA (en) | Peptide mapping method for sequence identification of insulin & insulin analogues |